Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human ESRRA Stable Cell Line

    [CAT#: S01YF-1123-KX97]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Nuclear Receptor

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Protein
    ESRRA
    Target Family
    Estrogen-related Receptor
    Target Protein Species
    Human
    Host Cell Type
    SCC084; SCC131; CHO-K1; HEK293
    Target Classification
    Nuclear Receptor
    Target Research Area
    Cancer Research; Reproductive Research
    Related Diseases
    Breast Lobular Carcinoma; Endometrial Cancer
    Gene ID
    UniProt ID

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    The ESRRA gene in humans encodes the nuclear receptor known as estrogen-related receptor alpha (ERRα), or NR3B1. ERRα is currently regarded as an orphan nuclear receptor. Although ERRα is widely distributed across tissues, it is most highly expressed in organs such the kidney, heart, brain, gut, brown adipose tissue, and skeletal muscle that preferentially use fatty acids as energy sources. Recently, ERRα has been found in normal tissues of the adrenal cortex; its expression may be associated with the development of the adrenals and may have a role in the function of the adrenals in fetal development, in the generation of DHEAS during adrenarche, and in the production of steroids throughout post-adrenarche and adult life. The customized ESRRA stable cell line can be used in antibody discovery and development, potential drug candidate screening and signaling pathway researches.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human ESRRA Stable Cell Line (S01YF-1123-KX97). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Charles (Verified Customer)

    What's the significance of ESRRA mutation? Jun 04 2022

    chat Sherry Smith (Creative Biolabs Scientific Support)

    ESRRA is an orphan nuclear receptor enriched in metabolically active tissues and has been known to affect the transcription of a set of genes that regulate mitochondrial bioenergetics in peripheral organs Jun 04 2022

    chat Emily (Verified Customer)

    What are other names for ESRRA? Mar 02 2023

    chat Sherry Smith (Creative Biolabs Scientific Support)

    This target may also be called "ERR1, ERRa, ESRL1, NR3B1, ERRalpha" in publications. Mar 02 2023

    Published Data

    Fig.1 Genomic amplification and expression of ESRRA in OSCC cell lines.

    Four copies of ESRRA were present in the SCC084 and SCC131 cell lines, respectively. In both cell lines, the amount of ESRRA protein was higher than in the normal oral tissue from patient #63.

    Ref: Tiwari, Ankana, et al. "Genomic amplification upregulates estrogen-related receptor alpha and its depletion inhibits oral squamous cell carcinoma tumors in vivo." Scientific Reports 5.1 (2015): 17621.

    Pubmed: 26639757

    DOI: 10.1038/srep17621

    Research Highlights

    Estrogen-related receptor α, also known as the orphan nuclear receptor, is a crucial modulator of mitochondrial activity and energy homeostasis. An essential innate effector against intracellular microorganisms is macroautophagy/autophagy, an intracellular breakdown process.
    Kim, Soo Yeon, et al. "ESRRA (estrogen-related receptor α) is a key coordinator of transcriptional and post-translational activation of autophagy to promote innate host defense." Autophagy 14.1 (2018): 152-168.
    Pubmed: 28841353   DOI: 10.1080/15548627.2017.1339001

    According to immunohistochemistry and transcriptome profiling, TN-ILC is a distinct aggressive breast cancer that is linked to advanced age and belongs to the luminal androgen receptor subtype. Additionally, it carries certain molecular changes (PI3K, ERBB2, and ESRRA) that could lead to the development of novel targeted treatment approaches.
    Bergeron, Anthony, et al. "Triple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutations." Modern Pathology 34.7 (2021): 1282-1296.
    Pubmed: 33753865   DOI: 10.1038/s41379-021-00742-9

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare